Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 69,423 | 64,179 | 74,141 | 66,865 | 68,914 |
| Cost of Goods | 38,582 | 38,335 | 35,108 | 36,686 | 43,273 |
| Gross Profit | 30,841 | 25,844 | 39,033 | 30,179 | 25,641 |
| Operating Expenses | 44,863 | 45,040 | 46,291 | 46,282 | 37,528 |
| Operating Income | -13,440 | -18,861 | -7,150 | -15,417 | -11,614 |
| Interest Expense | 11,939 | 10,864 | 15,400 | 11,637 | 7,022 |
| Other Income | 4,524 | 7,316 | 678,736 | 6,491 | 5,272 |
| Pre-tax Income | -20,855 | -22,409 | 656,186 | -20,563 | -13,364 |
| Income Tax | -2,435 | 271 | 766,168 | -5,461 | -1,421 |
| Net Income Continuous | -18,420 | -22,680 | -109,982 | -15,102 | -11,943 |
| Minority Interests | -8,631 | -10,602 | -4,023 | -8,640 | -5,402 |
| Net Income | $-9,789 | $-12,078 | $-105,959 | $-6,462 | $-6,541 |
| EPS Basic Total Ops | -0.07 | -0.09 | -0.80 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.14 | -0.17 | -0.83 | -0.11 | -0.09 |
| EPS Diluted Total Ops | -0.07 | -0.09 | -0.80 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.14 | -0.17 | -0.83 | -0.11 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.11 | -0.05 | N/A | N/A |
| EBITDA(a) | $1,851 | $-4,368 | $6,573 | $-1,583 | $913 |